Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 3/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.44 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.44 |
| ▸ | TRPV1 | Q8NER1 | 2/20 | 0.40 |
| ▸ | CETP | P11597 | 7/20 | 0.40 |
| ▸ | LTA4H | P09960 | 1/20 | 0.39 |
| ▸ | PIM1 | P11309 | 1/20 | 0.39 |
| ▸ | PIM2 | Q9P1W9 | 1/20 | 0.39 |
| ▸ | PTGES2 | Q9H7Z7 | 2/20 | 0.38 |
| ▸ | MAPT | P10636 | 1/20 | 0.36 |
| ▸ | CA4 | P22748 | 1/20 | 0.36 |
| ▸ | ABL1 | P00519 | 1/20 | 0.35 |
| ▸ | BCR | P11274 | 1/20 | 0.35 |
| ▸ | PRKCA | P17252 | 1/20 | 0.35 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6426423 | 0.88 | PTGES2 (0.42) | TSHRALDH1A1HSD17B10TRPV1CETP | |
| SCHEMBL1907911 | 0.87 | ALDH1A1 (0.48) | TSHRALDH1A1HSD17B10TRPV1CETP | |
| SCHEMBL7980644 | 0.87 | KIF11 (0.45) | TSHRALDH1A1HSD17B10TRPV1CETP | |
| SCHEMBL706601 | 0.84 | TSHR (0.62) | TSHRALDH1A1HSD17B10CETPLTA4H | |
| SCHEMBL498326 | 0.83 | PIM1 (0.48) | CETPPIM1PIM2MAPTABL1 | |
| SCHEMBL5670119 | 0.82 | CETP (0.54) | TSHRCETPLTA4H | |
| SCHEMBL20222969 | 0.81 | CA4 (0.39) | TSHRALDH1A1HSD17B10LTA4HCA4 | |
| SCHEMBL14241262 | 0.81 | TSHR (0.42) | TSHRALDH1A1HSD17B10CETPLTA4H | |
| SCHEMBL11643031 | 0.81 | TSHR (0.38) | TSHRALDH1A1HSD17B10LTA4HMAPT | |
| SCHEMBL28453663 | 0.81 | TSHR (0.39) | TSHRALDH1A1HSD17B10CETPLTA4H |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 105 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260106221-A1 | LITHIUM SECONDARY BATTERY WITH ENHANCED SAFETY | SOLVAY SPECIALTY POLYMERS IT (IT) | 2026-04-16 | — | — | US | claimed |
| EP-4602667-A1 | LITHIUM SECONDARY BATTERY WITH ENHANCED SAFETY | Solvay Specialty Polymers Italy S.p.A. (IT) | 2025-08-20 | — | — | EP | claimed |
| WO-2024078976-A1 | LITHIUM SECONDARY BATTERY WITH ENHANCED SAFETY | SOLVAY SPECIALTY POLYMERS ITALY S.P.A. (IT) | 2024-04-18 | — | — | WO | claimed |
| CN-115051032-A | Lithium ion battery electrolyte with negative electrode targeting passivation effect and preparation method thereof | 华中科技大学 | 2022-09-13 | — | — | CN | claimed |
| CN-110869319-A | Method for dinitrogen conversion, battery and electrolyte | 莫纳什大学 | 2020-03-06 | — | — | CN | claimed |
| US-9335636-B2 | Method of patterning a device | ORTHOGONAL, INC. (US) | 2016-05-10 | — | — | US | claimed |
| US-20150331325-A1 | METHOD OF PATTERNING A DEVICE | ORTHOGONAL, INC. | 2015-11-19 | — | — | US | claimed |
| US-9122167-B2 | Method of patterning a device | ORTHOGONAL, INC. (US) | 2015-09-01 | — | — | US | claimed |
| US-20140322656-A1 | METHOD OF PATTERNING A DEVICE | ORTHOGONAL, INC. | 2014-10-30 | — | — | US | claimed |
| US-20140248565-A1 | METHOD OF PATTERNING A DEVICE | ORTHOGONAL, INC. | 2014-09-04 | — | — | US | claimed |
| EP-1670446-A2 | METHOD OF INHIBITING REMNANT LIPOPROTEIN PRODUCTION | JAPAN TOBACCO INC. (JP) | 2006-06-21 | — | — | EP | claimed |
| WO-2005030185-A2 | METHOD OF INHIBITING REMNANT LIPOPROTEIN PRODUCTION | JAPAN TOBACCO INC. (JP) | 2005-04-07 | — | — | WO | claimed |
| EP-0064322-B1 | BENZENESULFONYL ISOCYANATES, ISOTHIOCYANATES, CHLORIDES, AND SULFONAMIDES HAVING A FLUORINATED SUBSTITUENT | E.I. DU PONT DE NEMOURS AND COMPANY (US) | 1985-05-22 | — | — | EP | claimed |
| US-20260106221-A1 | LITHIUM SECONDARY BATTERY WITH ENHANCED SAFETY | SOLVAY SPECIALTY POLYMERS IT (IT) | 2026-04-16 | — | — | US | disclosed |
| EP-4602667-A1 | LITHIUM SECONDARY BATTERY WITH ENHANCED SAFETY | Solvay Specialty Polymers Italy S.p.A. (IT) | 2025-08-20 | — | — | EP | disclosed |
| US-20240167177-A1 | BIPOLAR PLATE AND METHOD FOR PRODUCING SAME | REINZ-DICHTUNGS-GMBH (DE) | 2024-05-23 | — | — | US | disclosed |
| US-4423249-A | APROTIC SOLVENT, METAL HYDROCARBOXIDE, HALOFLUOROALKYL COMPOUND, ETHERIFICATION | THE DOW CHEMICAL COMPANY (US) | 1983-12-27 | — | — | US | disclosed |
| EP-0085265-A1 | Process for the preparation of alpha,alpha-difluoroalkoxy or alpha,alpha-difluoroalkylthiophenyl ketones | RHONE-POULENC SPECIALITES CHIMIQUES (FR) | 1983-08-10 | — | — | EP | disclosed |
| EP-0084743-A1 | Process for the preparation of alpha, alpha-difluoroalkoxy or alpha, alphadifluoroalkylthiophenyl sulfones | RHONE-POULENC SPECIALITES CHIMIQUES (FR) | 1983-08-03 | — | — | EP | disclosed |
| EP-0063873-A1 | Haloalkoxy-substituted diphenyl ethers; their use as herbicides and in herbicidal compositions and processes of making them | IMPERIAL CHEMICAL INDUSTRIES PLC (GB) | 1982-11-03 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260106221-A1 | LITHIUM SECONDARY BATTERY WITH ENHANCED SAFETY | BCL6B, CLCN2, SLC9A2 | TSHR 498/4885ALDH1A1 531/4885HSD17B10 1181/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.